Resverlogix Competitors and Similar CompaniesClear all

Resverlogix's competitors and similar companies include CRISPR Therapeutics and Lexicon Pharmaceuticals.

	Resverlogix Resverlogix is a clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses.	CRISPR Therapeutics CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.	Lexicon Pharmaceuticals Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
Founding Date	Founding Date 2001	Founding Date 2013	Founding Date 1995
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma
Locations	Locations Calgary, CA HQ San Francisco, US	Locations Zug, CH HQ Greater London, GB Cambridge, US San Francisco, US	Locations The Woodlands, US HQ Jersey, JE Atlanta, US Bernards, US Birmingham, US Boston, US Charlotte, US see more
Employees	Employees 19	Employees 393	Employees 20216% increase
Valuation ($)	Valuation ($) 12.9 m	Valuation ($) 4.2 b	Valuation ($) 737.4 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $3.5m (FY, 2025)	Revenue (est.) $49.8m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $274k (FY, 2025)
Gross profit	Gross profit $50k (FY, 2025)	Gross profit N/A	Gross profit $49.5m (FY, 2025)
Net income	Net income ($7.8m) (FY, 2025)	Net income ($581.6m) (FY, 2025)	Net income ($50.3m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 10m	Total funding raised $ 127m	Total funding raised $ 244.7m